CONMED Corp — Director's Dealing 2014

Dec 15, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-12-12

Reporting Person: JONAS DANIEL (EVP Legal Affairs,Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-12	Common Stock	M	2000	$27.63	Acquired	13306	Direct
2014-12-12	Common Stock	F	1534	$43.54	Disposed	11772	Direct
2014-12-12	Common Stock	M	2000	$26.09	Acquired	13772	Direct
2014-12-12	Common Stock	F	1489	$43.54	Disposed	12283	Direct
2014-12-12	Common Stock	M	2000	$32.93	Acquired	14283	Direct
2014-12-12	Common Stock	F	1689	$43.54	Disposed	12594	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-12	Sars (Stock Appreciation Rights)	$27.63	M	2000	Disposed	2021-06-01	Common Stock (2000)	Direct
2014-12-12	Sars (Stock Appreciation Rights)	$26.09	M	2000	Disposed	2022-06-01	Common Stock (2000)	Direct
2014-12-12	Sars (Stock Appreciation Rights)	$32.93	M	2000	Disposed	2023-06-01	Common Stock (2000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.